Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Treo Ventures, founded in 2018, focuses on advancing medical device and digital health innovations. The firm operates in the United States and Ireland, with a portfolio of 10 companies and a collective investment experience in over 40 companies globally. Their medical device accelerator, NuXcel, supports the development of novel medical technologies.
Treo Ventures invests in medical technology companies that address large unmet clinical needs, targeting both early-stage and later-stage investments. They typically back companies with demonstrated feasibility and clinical data, primarily in the healthcare, digital health, and biotech sectors. Their geographical focus includes the United States and Europe.
Notable portfolio companies include Avivomed, SecondWave Systems, Inc., iVEAcare, InterVene, Noctrix Health, Neuspera Medical, CVRx, Hyalex, NeoChord, and ShiraTronics.
Mudit Jain, PhD and Brad Vale, PhD, DVM co-founded Treo Ventures, bringing extensive experience in healthcare investing and a focus on medical technology.
Treo Ventures operates the NuXcel medical device accelerator, which supports the development of novel medical technologies. Startups can apply through their website for access to resources and mentorship.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.